Skip to main content
SpringerLink
Log in
Book cover

Cancer Therapeutics pp 175–193Cite as

The Taxoids

  • Chapter

  • 175 Accesses

Part of the book series: Cancer Drug Discovery and Development ((CDD&D))

Abstract

Paclitaxel and docetaxel belong to the taxoid family, a new class of antineoplastic drugs. The name taxoids refers to compounds, natural or modified, having a taxane skeleton.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Suffness M. Taxol: from discovery to therapeutic use. In: Bristol JA ed. Annual Reports in Medicinal Chemistry. San Diego, CA: Academic 1993: 305–314.

    Google Scholar 

  2. Wall ME. Camptothecin and taxol. In: Lednicer D, ed. Chronicles of Drug Discovery. Washington DC: American Chemical Society. 1993: 327–348.

    Google Scholar 

  3. Wall ME, Wani MC. Campthothecin and taxol: discovery to clinic—Thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 1995; 55: 753–760.

    PubMed  CAS  Google Scholar 

  4. Wall ME, Wani MC. Recent progress in plant anti-tumor agents. In: 153rd National Meeting of the American Chemical Society, Miami Beach FL, 1967; Paper M-006.

    Google Scholar 

  5. Wani MC, Taylor HL, Wall ME, Coggon P, Mc Phail AT. Plant antitumor agents VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 1971; 93: 2325–2327.

    Google Scholar 

  6. Douros J, Suffness M. New natural products under development at the National Cancer Institute. Recent results. Cancer Res 1981; 76: 153–175.

    Google Scholar 

  7. Fuchs DA, Johnson RK. Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison. Cancer Treat Rep 1978; 62: 1219–1222.

    PubMed  CAS  Google Scholar 

  8. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by Taxol. Nature 1979; 22: 665–667.

    Article  Google Scholar 

  9. Pazdur R, Kudelka AP, Kavanagh JJ, Cohen PR, Raber MN. The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere°). Cancer Treatment Rev 1993; 19: 351–386.

    Article  CAS  Google Scholar 

  10. Rowinsky EK, Cazenave LA, Donehower RC. Taxol: A novel investigational antimicrotubule agent. J Natl Cancer Inst 1990; 82 (15): 1247–1259.

    Article  PubMed  CAS  Google Scholar 

  11. McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989; 111: 273–279.

    PubMed  CAS  Google Scholar 

  12. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 1991: 83: 1797–1805.

    Article  PubMed  CAS  Google Scholar 

  13. Murphy WK, Fossella FV, Winn RJ, Shin DM, Hynes HE, Gross HM, Davilla E, Leimert JT, Dhingra HM, Raber MN, Krakoff IH, Hong WK. Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer. J Natl Cancer Inst 1993; 85: 384–388.

    Article  PubMed  CAS  Google Scholar 

  14. Shelanski ML, Gaskin F, Cantor CR. Microtubule assembly in the absence of added nucleotides. Proc Nall Acad Sci USA 1973; 70: 765–769.

    Article  CAS  Google Scholar 

  15. Senilh V, Blechert S, Colin M, Guénard D, Picot F, Potier P, Varenne P. Mise en évidence de nouveaux analogues du taxol, extraits de Taxus baccara. J Natural Product 1984; 47: 131.

    Article  CAS  Google Scholar 

  16. Lavelle F, Guéritte-Voegelein F, Guénard D, Le Taxotere: des aiguilles d’if a la clinique. Bull Cancer (Paris) 1993; 80: 326–338.

    CAS  Google Scholar 

  17. Guéritte-Voegelein F, Senilh V, David B, Guénard D, Potier P. Chemical studies of 10-deacetylbaccatin III. Hemisynthesis of taxol derivatives. Tetrahedron 1986; 42: 4451–4460.

    Article  Google Scholar 

  18. Guénard D, Guéritte-Voegelein F, Potier P. Taxol and Taxotere: discovery, chemistry and structure-activity relationships. Acc Chem Res 1993; 26: 160–167.

    Article  Google Scholar 

  19. Herranz E, Biller SA, Sharpless KB. Osmium-catalyzed vicinal oxyamination of olefins by N-chloro-N-argentocarbamates. J Am Chem Soc 1978; 100: 3596–3598.

    Article  CAS  Google Scholar 

  20. Mangatal L, Adeline MT, Guénard D, Guéritte-Voegelein F, Potier P. Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analogues. Tetrahedron 1989; 45: 4177–4190.

    Article  CAS  Google Scholar 

  21. Lavelle F, Fizames C, Guéritte-Voegelein F, Guénard D, Potier P. Experimental properties of RP 56976, a Taxol derivative. Proc Am Assoc Cancer Res 1989; 30: 2254.

    Google Scholar 

  22. Denis JN, Greene AE, Serra AA, Luche MJ. An efficient, enantioselective synthesis of the taxol side chain. J Org Chem 1986; 51: 46–50.

    Article  CAS  Google Scholar 

  23. Colin M, Guénard D, Guéritte-Voegelein F, Potier P. Preparation of baccatin III derivatives as antitumor agents. Eur. Pat. Appl EP 336841, 89/10/11, FR appl. 884513 (88/04/06).

    Google Scholar 

  24. Denis JN, Greene AE, Guénard D, Guéritte-Voegelein F, Mangatal L, Potier P. A highly effiicient, practical approach to natural taxol. J Am Chem Soc 1988; 110: 5917–5919.

    Article  CAS  Google Scholar 

  25. Commercon A, Bézard D, Bernard F, Bourzat JD. Improved protection and esterification of a precursor of the Taxotere° and Taxol° side chain. Tetrahedron Lett 1992; 33: 5185.

    Article  CAS  Google Scholar 

  26. Holton RA. Eur. Pat. Appl. EP 400,971, 1990. Chem. Abstr. 1991: 114, 164568q.

    Google Scholar 

  27. Holton RA. Eur. Pat. Appl. EP 428,376, 1991. Chem. Abstr. 1991: 115, 114817v.

    Google Scholar 

  28. Ojima I, Habus I, Zhao M, Georg G, Jayasinghe LR. Efficient and practical asymmetric synthesis of the Taxol C-13 side chain, N-Benzoyl-(2R,3S)-3-phenylisoserine, and its analogues via chiral 3-hydroxy-4-aryl-ß-lactams through chiral ester enolate-imine cyclocondensation. J Org Chem 1991; 56: 1681.

    Article  CAS  Google Scholar 

  29. Bissery MC, Guénard D, Guéritte-Voegelein F, Lavelle F. Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 1991; 51: 4845–4852.

    PubMed  CAS  Google Scholar 

  30. Verweij J, Clavel M, Chevalier B. Paclitaxel (Taxo1TM) and docetaxel (TaxotereTM): Not simply two of a kind. Ann Oncol 1994; 5: 495–505.

    PubMed  CAS  Google Scholar 

  31. Hyams JS, Lloyd CW. in: Harford JB, ed. Microtubules, Modern Cell Biology Series, vol. 13. New York: Wiley Liss. 1993: 460.

    Google Scholar 

  32. Wadsworth P. Mitosis: spindle assembly and chromosome motion. Current Opinion Cell Biol 1993; 5: 123–128.

    Article  PubMed  CAS  Google Scholar 

  33. Beese L, Stubbs G, Cohen C. Microtubule structure at 18 A resolution. J Mol Biol 1987; 194: 257–264.

    Article  PubMed  CAS  Google Scholar 

  34. Gaskin F, Cantor CR, Shelanski ML. Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules. J Mol Biol 1974; 89: 737–758.

    Article  PubMed  CAS  Google Scholar 

  35. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature (Loud.) 1979; 22: 665–667.

    Article  Google Scholar 

  36. Ringel I, Horwitz SB. Studies with RP 56976 (Taxotere): a semi-synthetic analog of taxol. J Natl Cancer Inst 1991; 83: 288–291.

    Article  PubMed  CAS  Google Scholar 

  37. Guéritte-Voegelein F, Guénard D, Lavelle F, Le Goff M-T, Mangatal L, Potier P. Relationships between the structure of Taxol analogues and their antimitotic activity. J Med Chem 1991; 34: 992–998.

    Article  PubMed  Google Scholar 

  38. Diaz JF, Andreu JM. Assembly of purified GDP-tubulin into microtubules induced by RP 56976 and paclitaxel: reversibility, ligand stoichiometry and competition. Biochemistry 1993; 32: 2747–2755.

    Article  PubMed  CAS  Google Scholar 

  39. Karsenti E. Vers une description du mécanisme d’assemblage du fuseau mitotique a l’échelle moléculaire. Méd/Sci 1993; 9: 131–139.

    Google Scholar 

  40. Parness J., Horwitz SB. Taxol binds to polymerized tubulin in vitro. J Cell Biol 1981; 91: 479–487.

    Article  PubMed  CAS  Google Scholar 

  41. Schiff PB, Horwitz SB. Taxol assembles tubulin in the absence of exogenous guanosine-5 ’-triphosphate or microtubule associated proteins. Biochemistry 1981; 20: 3247–3252.

    Article  PubMed  CAS  Google Scholar 

  42. Kumar N. Taxol induced polymerization of purified tubulin. J Bio! Chem 1981; 256: 10,435–10,441.

    Google Scholar 

  43. Diaz JF, Menendez M, Andreu JM. Thermodynamics of ligand-induced assembly of tubulin. Biochemistry 1993;32:10, 067–10, 077.

    Google Scholar 

  44. Andreu JM, Bordas J, Diaz JF, Garcia De Ancos J, Gil R, Medrano FJ, Nogales E, Pantos E, Towns-Andrews E. Low resolution structure of microtubules in solution. J Mol Bio 1992; 226: 169–184.

    Article  CAS  Google Scholar 

  45. Andreu JM, Diaz JF, Gil R, De Pereda JM, Garcia De Lacoba M, Peyrot V, Briand C, Towns-Andrews E, Bordas J. Solution structure of microtubules induced by the side chain taxol analogue Taxotere to 3 nm resolution. JBiol Chem 1994; 269 no 50:31, 785–31, 792.

    Google Scholar 

  46. Riou JF, Naudin A, Lavelle F. Effects of Taxotere on murine and human tumor cell lines. Biochem Biophys Res Commun 1992; 187: 164–170.

    Article  PubMed  CAS  Google Scholar 

  47. Kelland LR, Abel G. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatinsensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmaco 1992; 30: 444–450.

    Article  CAS  Google Scholar 

  48. Vogel M, Hilsenbeck SG, Depenbrock H, Danhauser-Ried1 S, Block T, Nekarda H, Fellbaum C, Aapro MS, Bissery MC, Rastetter J, Hanauske AR. Preclinical activity of Taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: comparison with taxol and conventional antineoplastic agents. Eur J Cancer 1993; 29A: 2009–2014.

    Article  Google Scholar 

  49. Hanauske AR, Degen D, Hilsensbeck SG, Bissery MC, Von Hoff DD. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells. Anti-Cancer Drugs 1992; 3: 121–124.

    Article  PubMed  CAS  Google Scholar 

  50. Braakhuis BJM, Hill BT, Dietel M, Kelland LR, Aapro MS, Zoli W, Lelieveld P. In vitro anti-proliferative activity of docetaxel (Taxotere®), paclitaxel (Taxol®) and Cisplatin against human tumors and normal bone marrow cells. Anticancer Res 1994; 14: 205–208.

    PubMed  CAS  Google Scholar 

  51. Riou JF, Petitgenet O, Combeau C and Lavelle F. Cellular uptake and efflux of docetaxel (Taxotere®) and paclitaxel (Taxol®) in P388 cell line. Proc Am Assoc Cancer Res 1994; 35: 385.

    Google Scholar 

  52. Lopes NM, Adams EG, Pitts TW, Bhuyan BK. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmaco 1993; 32: 235–242.

    Article  CAS  Google Scholar 

  53. Roberts JR, Allison DC, Donehower RC, Rowinsky EK. Development of polyploidization in Taxol-resistant human leukemia cells in vitro. Cancer Res 1990; 50: 710–716.

    CAS  Google Scholar 

  54. Long BH, Fairchild CR. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telophase. Cancer Res 1994; 54: 4355–4361.

    PubMed  CAS  Google Scholar 

  55. Garcia P, Braguer D, Carles G, El Khyari S, Barra Y, De Ines C, Barasoain I, Briand C. Comparative effects of taxol and Taxotere on two different human carcinoma cell lines. Cancer Chemother Pharmaco 1994; 34: 335–343.

    Article  CAS  Google Scholar 

  56. Hennequin N, Giocanti N, Favaudon V. S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells. Br J Cancer 1995; 71: 1194–1198.

    Article  PubMed  CAS  Google Scholar 

  57. De Brabander M, Geuens G, Nuydens R, Willebrords R, De Mey J. Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. Proc Nall Acad Sci USA 1981; 78: 5608–5612.

    Article  Google Scholar 

  58. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblasts cells. Proc Natl Acad Sci 1980; 77: 1561–1565.

    Article  PubMed  CAS  Google Scholar 

  59. Rose WC. Taxol: a review of its preclinical in vivo antitumor activity. Anti-Cancer Drugs 1992; 3: 311–321.

    Article  PubMed  CAS  Google Scholar 

  60. Rose WC. Taxol-based combination chemotherapy and other in vivo preclinical antitumor studies. JNCI Monographs 1993; 15: 47–53.

    Google Scholar 

  61. Riondel J, Jacrot M, Picot F, Beriel H, Mouriquand C, Potier P. Therapeutic response to taxol of six human tumors xenografted into nude mice. Cancer Chemother Pharmacol 1986; 17: 137–142.

    Article  CAS  Google Scholar 

  62. Nicoletti MI, Lucchini V, D’Incalci M, Giavazzi R. Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts. Eur J Cancer 1994; 30A: 5: 691–696.

    Article  Google Scholar 

  63. Bissery MC, Vrignaud P, Lavelle F. Preclinical profile of Docetaxel (Taxotere): Efficacies as a single agent or in combination. Seminars in Oncology 1995; 22 (Suppl): 3–16.

    CAS  Google Scholar 

  64. Dykes DJ, Bissery MC, Harrison SD, Waud WR. Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere°). Invest New Drugs 1995; 13: 1–11.

    Article  PubMed  CAS  Google Scholar 

  65. Boven E, Venema-Gaberscek E, Erkelens CAM, Bissery MC, Pinedo HM. Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer. Ann Oncol 1993; 4: 321–324.

    PubMed  CAS  Google Scholar 

  66. Braakhuis BJM, Kegel A, Welters MJP. The growth inhibiting effect of docetaxel (Taxotere®) in head and neck squamous cell carcinoma xenografts. Cancer Lett 1994; 81: 151–154.

    Article  PubMed  CAS  Google Scholar 

  67. Hahn SM, Liebmann JE, Cook J, Fisher J, Goldspiel B, Venzon D, Mitchell JB, Kaufman D. Taxol in combination with doxorubicin or etoposide. Cancer 1993; 72: 2705–2711.

    Article  PubMed  CAS  Google Scholar 

  68. Citardi MJ, Rowinsky EK, Schaefer KL, Donehower RC. Sequence dependent cytotoxicity between cisplatin (C) and the antimicrotubule agents taxol (T) and vincristine (V). Proc Am Assoc. Cancer Res 1990; 31: 24–31.

    Google Scholar 

  69. Speicher LA, Barone L, Tew KD. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines. Cancer Res 1992; 52: 4433–4440.

    PubMed  CAS  Google Scholar 

  70. Lorusso PM, Demchik LL, Plowman J, Baker L, Corbett TH. Preclinical activity and toxicity of taxol combinations. Proc Am Assoc Cancer Res 1993; 34: 1794.

    Google Scholar 

  71. Bissery MC, Vrignaud P, Bayssas M, Lavelle F. In vivo evaluation of Taxotere (RP 56976, NSC 628503) in combination with cisplatin, doxorubicin or vincristine. Proc Am Assoc Cancer Res 1992; 33: 443.

    Google Scholar 

  72. Bissery MC, Vrignaud P, Bayssas M, Lavelle F. Taxotere synergistic combination with cyclophosphamide, etoposide and 5-fluorouracil in mouse tumor models. Proc Am Assoc Cancer Res 1993; 34: 1782.

    Google Scholar 

  73. Hamel E, Lin CM, Johns DG. Tubulin dependent biochemical assay for the antineoplastic agent taxol and application of the drug in serum. Cancer Treat Rep 1982; 66: 1381–1386.

    PubMed  CAS  Google Scholar 

  74. Vergniol JC, Bruno R, Montay G, Frydman A. Determination of Taxotere in human plasma by a semiautomated high-performance liquid chromatographic method. J Chromatog 1992; 582: 273–278.

    Article  CAS  Google Scholar 

  75. Bissery MC, Renard A, André S., et al. Preclinical pharmacology and toxicology of Taxotere (RP 56976, NSC 628503). Ann Oncol 1992; 3 (suppl 1): 121.

    Google Scholar 

  76. Bissery MC, Renard A, Montay G, Bayssas M, Lavelle F. Taxotere:Antitumor activity and pharmacokinetics in mice. Proc Am Assoc Cancer Res 1991; 32: 401.

    Google Scholar 

  77. Bruno R, Sanderink GJ. Pharmacokinetics and metabolism of TaxotereTM. Cancer Surveys 1993; 17: 305–313.

    PubMed  CAS  Google Scholar 

  78. Marlard M, Gaillard C, Sanderink GJ, Roberts SA, Joannou PP, Facchini V, Chapelle P, Frydman A. Kinetics, distribution, metabolism and excretion of radiolabelled Taxotere® (’4C-RP 56976, docetaxel) in mice and dogs. Proc Am Assoc Cancer Res 1993; 34: 393.

    Google Scholar 

  79. Sanderink GJ, Martinet M, Touzet A, Chapelle P, Frydman A. Docetaxel (Taxotere°), RP 56976) metabolizing enzymes and metabolic drug-drug interactions in vitro. Proc ISSX 1993; 3: 35.

    Google Scholar 

Download references

Authors
  1. Marie-Christine Bissery PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. François Lavelle PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dana-Farber Cancer Institute, Boston, MA, USA

    Beverly A. Teicher

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bissery, MC., Lavelle, F. (1997). The Taxoids. In: Teicher, B.A. (eds) Cancer Therapeutics. Cancer Drug Discovery and Development. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-717-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-717-8_8

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-046-5

  • Online ISBN: 978-1-59259-717-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation